NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering the NIAID New Innovator Awards (DP2 Clinical Trial Not Allowed) to support early-stage, creative biomedical researchers proposing innovative research concepts in infectious diseases, immunology, and allergies. This grant opportunity is aimed at postdoctoral researchers and newly independent Early Stage Investigators, allowing them to request up to $300,000 annually for a maximum of five years to foster groundbreaking research that may not yet have sufficient preliminary data. Applications must be submitted through the Grants.gov platform by 5 PM local time on October 10, 2025, and will be evaluated based on significance, innovation, investigator qualifications, and overall impact. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.